Search company, investor...

Predict your next investment

Angel Investor (Individual)

Investments

24

Portfolio Exits

3

About Marius Nacht

Headquarters Location

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Marius Nacht News

Healthtech startup DayTwo facing uncertain future after dramatic restructuring

Jul 6, 2023

The Israeli startup, which raised $85 million mainly from co-founder Marius Nacht, has reduced its staff by over 75% over the past year and is hoping to sell its technology to another company Sophie Shulman After much buzz and hype, Israeli nutrition company DayTwo is nearing the end of its journey. The company, co-founded and primarily funded by Marius Nacht, is reducing most of its operations and retaining only a small core team for development and customer service in Israel and the U.S., according to Calcalist's sources. The aim is to provide support to existing customers and potentially sell its technology to an external party. The company employed 150 staff in 2022, but currently only has 35 employees remaining, with 20 in Israel and 15 in the U.S. (Photo: Orel Cohen) DayTwo raised $85 million to develop and market kits that personalized proper nutrition for diabetic patients based on their stool samples. The company's unique approach meant it would sometimes recommend foods like pizza, hamburgers with fries, or bread with butter, which it believed could be healthier for certain individuals. Through genetic analysis and sugar tests, the system provided personalized adjustments to food choices. While DayTwo demonstrated positive results in improving sugar levels, weight loss outcomes were inconclusive. Criticism also arose over the recommendation of foods that, despite their sugar-lowering benefits, were deemed unhealthy. Despite initial enthusiasm and marketing through Israeli HMOs Maccabi and Clalit, who charged a one-time payment for the kits, the company's business model failed to generate profitability. Two years ago, CEO Lihi Segal, one of the founders, departed, and Dave Henderson, an American CEO, took over. The plan was to enter the U.S. market and adopt a subscription model with organizations and insurance companies, some of which signed agreements with the company. However, the emergence of diabetes injections like Ozempic, which offer both sugar level management and weight loss benefits, undermined DayTwo's target population. Starting in 2023, cooperation between DayTwo and Maccabi and Clalit came to an end and it is no longer possible to order new kits. Only support for existing customers is provided. Calcalist also discovered that the company recently sold its laboratory and shifted operations to the U.S. through distributors. At the end of 2022, a significant downsizing took place, resulting in the dismissal of dozens of employees in both Israel and the U.S. DayTwo conducted further layoffs in recent weeks, including senior personnel. Related articles:

Marius Nacht Investments

24 Investments

Marius Nacht has made 24 investments. Their latest investment was in WaveBL as part of their Series B - II on June 6, 2023.

CBI Logo

Marius Nacht Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/6/2023

Series B - II

WaveBL

$26M

No

2

1/5/2023

Series A - II

Wisdo

$5M

Yes

3

5/31/2022

Series A

Ultima Genomics

$600M

Yes

3

1/11/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

1/11/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/6/2023

1/5/2023

5/31/2022

1/11/2022

1/11/2022

Round

Series B - II

Series A - II

Series A

Series B

Series A

Company

WaveBL

Wisdo

Ultima Genomics

Subscribe to see more

Subscribe to see more

Amount

$26M

$5M

$600M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

3

10

10

Marius Nacht Portfolio Exits

3 Portfolio Exits

Marius Nacht has 3 portfolio exits. Their latest portfolio exit was GK8 on November 01, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/1/2021

Acquired

$99M

6

7/9/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/10/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/1/2021

7/9/2019

4/10/2018

Exit

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

6

10

10

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.